APOL1 image
AP
APOL1: Apolipoprotein L1
Bessie Young
AS
ASCEND: A Trial of Sertraline vs. CBT for End-Stage Renal Disease Patients with Depression
Rajnish Mehrotra
PCORI
AS
ASPIRED: Assessing Patient-Reported Experience of Care for Home Dialysis
Matthew Rivara
Satellite Healthcare
AS
ASSESS-AKI: Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury
Jonathan Himmelfarb
NIDDK

Jonathan Himmelfarb, MD

Bi
Bio-PD: Biological Determinants of Peritoneal Dialysis
Rajnish Mehrotra
NIDDK
CA
CANDY CANE: Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease – Changing Glucose Management
Ian de Boer
ADA
CGM on arm
CA
CANDY: Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease
Ian de Boer
ADA
CA
CASIS: Chips in Space
Edward J. Kelly
NCATS
CA
CATCH: A Prospective Clinical Study to EvaluAte the AbiliTy of the CloudCath System to Detect Peritonitis
Rajnish Mehrotra
GastroKlenz, Inc. (CloudCath)
Ce
Cellular and Molecular Mechanisms of COVID-19 Mediated Kidney Injury
Jonathan Himmelfarb
NCATS

Jonathan Himmelfarb, MD

CH
CHROME: COVID-19 Host Response and Clinical Outcomes
Mark Wurfel
The Gates Foundation
CL
CLEAR: Clearance of 25-hydroxyvitamin D in chronic kidney disease
Ian de Boer
NIDDK
Co
CoNR: Cross-over Randomized Controlled Trial of Coenzyme Q10 or Nicotinamide Riboside in Chronic Kidney Disease
Bryan Kestenbaum
NIDDK
Co
Conservative Care for Advanced Kidney Disease
Susan P. Y. Wong
NPCRC
ES
ESTEEM: Exercise Study Testing Enhanced Energetics of Muscle Mitochondria in Chronic Kidney Disease
Baback Roshanravan
NIDDK

Baback Roshanravan, MD

Ex
Experiences of older adults with kidney failure and their family members related to the transplant evaluation process
Kate Butler
NIDDK
GL
GLUTE: Randomized Trial of Glutamine in Chronic Kidney Disease
Jonathan Himmelfarb
NIDDK / NY Medical College

Jonathan Himmelfarb, MD

He
Healthy Kidney Study
Ian de Boer
NIH
He
Heart Failure and Atrial Arrhythmias in CKD
Nisha Bansal
NIDDK
HO
HOPE:The Hemodialysis Opioid Prescription Effort Consortium
Rajnish Mehrotra
NIH
IC
ICICLE: Impact of Cirrhosis on Kidney Secretory Clearance
Bryan Kestenbaum
UW Royalty Research Fund
LU
LUCID: Longitudinal U.S./Canada Incident Dialysis Study
Jonathan Himmelfarb
Massachusetts General Hospital

Jonathan Himmelfarb, MD

ME
MEND: Muscle Mitochondria Energetics in Chronic Kidney Disease
Bryan Kestenbaum
NIDDK
ME
MENTOR: Membranous Nephropathy Trial Of Rituximab
Ashley Jefferson
Mayo Clinic
PD
PDOPPS: Peritoneal Dialysis Outcomes and Practice Patterns Study
Rajnish Mehrotra
NIDDK
kidney drawing
PE
PERL: Preventing Early Renal Loss
Ian de Boer
Joslin Diabetes Center
RBK logo
RB
RBK: Rebuilding a Kidney
Stuart Shankland
NIDDK
RO
ROKIT: COVOD-19 Supplement
Bryan Kestenbaum
NIDDK
SL
SLEEP-HD
Rajnish Mehrotra
NIDDK